Toggle light / dark theme

In what’s being hailed as an important first for chemistry, an international team of scientists has developed a new technology that can selectively rearrange atomic bonds within a single molecule. The breakthrough allows for an unprecedented level of control over chemical bonds within these structures, and could open up some exciting possibilities in what’s known as molecular machinery.

Molecules are made up of clusters of atoms, and are the product of the nature and arrangement of those atoms within. Where oxygen molecules we breathe feature the same repeating type of atom, sugar molecules are made of carbon, oxygen and hydrogen.

Scientists have been pursuing something called “selective chemistry” for some time, with the objective of forming exactly the type of chemical bonds between atoms that they want. Doing so could lead to the creation of complex molecules and devices that can be designed for specific tasks.

From pv magazine Australia

Sydney-based manufacturer Canyon Solar has launched a modular solar carport solution for commercial applications that has been specifically designed for rapid installation with company director Will Beaumont claiming the time-saving translates into a significant reduction in site labor requirements and a corresponding cost saving for clients.

Microplastics, tiny particles of plastic that are now found worldwide in the air, water, and soil, are increasingly recognized as a serious pollution threat, and have been found in the bloodstream of animals and people around the world.

Some of these microplastics are intentionally added to a variety of products, including agricultural chemicals, paints, cosmetics, and detergents—amounting to an estimated 50,000 tons a year in the European Union alone, according to the European Chemicals Agency. The EU has already declared that these added, nonbiodegradable microplastics must be eliminated by 2025, so the search is on for suitable replacements, which do not currently exist.

Now, a team of scientists at MIT and elsewhere has developed a system based on silk that could provide an inexpensive and easily manufactured substitute. The new process is described in a paper in the journal Small, written by MIT postdoc Muchun Liu, MIT professor of civil and environmental engineering Benedetto Marelli, and five others at the chemical company BASF in Germany and the U.S.

Using data collected over two decades ago, scientists from the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, have compiled the first complete map of hydrogen abundances on the Moon’s surface. The map identifies two types of lunar materials containing enhanced hydrogen and corroborates previous ideas about lunar hydrogen and water, including findings that water likely played a role in the Moon’s original magma-ocean formation and solidification.

APL’s David Lawrence, Patrick Peplowski and Jack Wilson, along with Rick Elphic from NASA Ames Research Center, used orbital data from the Lunar Prospector mission to build their map. The probe, which was deployed by NASA in 1998, orbited the Moon for a year and a half and sent back the first direct evidence of enhanced at the lunar poles, before impacting the .

When a star explodes, it releases , or high-energy protons and neutrons that move through space at nearly the speed of light. When those cosmic rays come into contact with the surface of a planet, or a moon, they break apart atoms located on those bodies, sending protons and neutrons flying. Scientists are able to identify an element and determine where and how much of it exists by studying the motion of those protons and neutrons.

TEL AVIV, Israel — A one-time vaccine for HIV is a step closer to reality, according to a new study. A team in Israel used gene-editing technology to engineer type B white blood cells, which can trigger the immune system to fight the virus.

Dr. Adi Barzel of Tel Aviv University says this is one of the few times scientists have been able to engineer B cells outside of the human body. Their study finds that B white blood cells spark the immune system to produce more HIV-neutralizing antibodies. Currently, there is no cure for AIDS, which the HIV virus causes.

“Based on this study, we can expect that over the coming years we will be able to produce a medication for AIDS, additional infectious diseases and certain types of cancer caused by a virus, such as cervical cancer, head and neck cancer and more,” Dr. Barzel says in a university release.